EUVIMEDObjevte EUVIMED
Multizentrische StudieOpen access · CC BY 4.0

Prevalence and Determinants of Sensitisation to Neomycin in North‐Eastern Italy, 1997–2021

Luca Cegolon iD, Francesca Larese Filon iD, North‐East Research Group on Contact Dermatitis

Contact Dermatitis · 2025

DOI: 10.1111/cod.14730 ↗

At a glance

Multizentrische Studie in Contact Dermatitis, 2025. Written by Luca Cegolon and 2 co-authors. Institution: Department of Medical, Surgical & Health Sciences, University of Trieste, Trieste, Italy. Major MEDLINE topics: Neomycin, Dermatitis, Allergic Contact, Anti-Bacterial Agents. Cited 4 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Allergic contact dermatitis (ACD) induced by topical application of neomycin is frequently reported.

Objectives

This multi‐center study investigated prevalence and determinants of neomycin sensitisations in 30 629 outpatients from North‐eastern Italy during 1997–2021. Patients and Methods European baseline and extended Triveneto series were applied on the upper back of patients patch testing for suspected ACD and removed after 48 h.

Results

Prevalence of neomycin sensitisation was 2.29% (=701/30 629), significantly decreasing over time, especially after 2003. Neomycin sensitisation increased with age, especially in female patients older than 60 with leg dermatitis. The majority of patients sensitised to neomycin (74.5%) tested positive also against other haptens, particularly ingredients included in creams and emollients, as lanolin or benzocaine or preservatives as thimerosal or parabens.

Conclusions

The decreasing prevalence of neomycin sensitisation over time likely reflected reduced accessibility and circulation of neomycin in Italy, due to containment of prescriptions and over‐the‐counter accessibility. Older individuals are typically more likely to be treated by topical medications and antibiotics as neomycin for various conditions, including stasis dermatitis. Since ACD caused by topical medications is relatively easy to miss, comprehensive drug history and patch testing are essential for any patient with suspected sensitisation caused by neomycin.

Subjects

MeSH terms (MEDLINE)

NeomycinDermatitis, Allergic ContactAnti-Bacterial AgentsHumansItalyFemalePatch TestsMaleMiddle AgedPrevalenceAdultAgedYoung AdultAdolescentChild

Author keywords

allergic contact dermatitisepidemiologyhaptenneomycinpatch testprevalencesensitisation

Substances

NeomycinAnti-Bacterial Agents

Authors and institutions

  • Department of Medical, Surgical & Health Sciences, University of Trieste, Trieste, Italy.
  • Public Health Department, University Health Agency Giuliano-Isontina (ASUGI), Trieste, Italy.
  • Occupational Medicine Unit, University Health Agency Giuliano-Isontina (ASUGI), Trieste, Italy.
  • Anna Belloni Fortina, University of Padua, Italy.
  • Erika Giulioni, Azienda Sanitaria Friuli Occidentale, Pordenone, Italy.

ORCID profiles: Luca Cegolon, Francesca Larese Filon

Cite

APA

Cegolon, L., Larese Filon, F., & North‐East Research Group on Contact Dermatitis (2025). Prevalence and Determinants of Sensitisation to Neomycin in North‐Eastern Italy, 1997–2021. Contact Dermatitis. https://doi.org/10.1111/cod.14730

Vancouver

Cegolon L, Larese Filon F, North‐East Research Group on Contact Dermatitis. Prevalence and Determinants of Sensitisation to Neomycin in North‐Eastern Italy, 1997–2021. Contact Dermatitis. 2025. doi:10.1111/cod.14730

BibTeX
@article{Cegolon2025,
  author = {Cegolon, Luca and Larese Filon, Francesca and North‐East Research Group on Contact Dermatitis, North‐East Research Group on Contact Dermatitis},
  title = {Prevalence and Determinants of Sensitisation to Neomycin in North‐Eastern Italy, 1997–2021},
  journal = {Contact Dermatitis},
  year = {2025},
  doi = {10.1111/cod.14730}
}
Start for free →